412 related articles for article (PubMed ID: 32229319)
1. Cannabidiol and tetrahydrocannabinol concentrations in commercially available CBD E-liquids in Switzerland.
Grafinger KE; Krönert S; Broillet A; Weinmann W
Forensic Sci Int; 2020 May; 310():110261. PubMed ID: 32229319
[TBL] [Abstract][Full Text] [Related]
2. Content versus Label Claims in Cannabidiol (CBD)-Containing Products Obtained from Commercial Outlets in the State of Mississippi.
Gurley BJ; Murphy TP; Gul W; Walker LA; ElSohly M
J Diet Suppl; 2020; 17(5):599-607. PubMed ID: 32431186
[TBL] [Abstract][Full Text] [Related]
3. An assessment of qualitative and quantitative cannabinoids analysis in selected commercially available cannabis oils in Argentina.
Fernández N; Cappello MG; Quiroga PN
Forensic Sci Int; 2023 Aug; 349():111762. PubMed ID: 37392612
[TBL] [Abstract][Full Text] [Related]
4. The analysis of cannabinoids in e-cigarette liquids using LC-HRAM-MS and LC-UV.
Barhdadi S; Courselle P; Deconinck E; Vanhee C
J Pharm Biomed Anal; 2023 Jun; 230():115394. PubMed ID: 37062207
[TBL] [Abstract][Full Text] [Related]
5. Using the BMD Approach to Derive Acceptable Daily Intakes of Cannabidiol (CBD) and Tetrahydrocannabinol (THC) Relevant to Electronic Cigarette Liquids.
Hindelang P; Scharinger A; Richling E; Walch SG; Lachenmeier DW
Front Biosci (Landmark Ed); 2022 Jul; 27(8):228. PubMed ID: 36042166
[TBL] [Abstract][Full Text] [Related]
6. Analysis of Cannabidiol, Δ
ElSohly MA; Murphy TP; Khan I; Walker LW; Gul W
Med Cannabis Cannabinoids; 2020 Aug; 3(1):1-13. PubMed ID: 34676337
[TBL] [Abstract][Full Text] [Related]
7. Concentrations of THC, CBD, and CBN in commercial hemp seeds and hempseed oil sold in Korea.
Jang E; Kim H; Jang S; Lee J; Baeck S; In S; Kim E; Kim YU; Han E
Forensic Sci Int; 2020 Jan; 306():110064. PubMed ID: 31786513
[TBL] [Abstract][Full Text] [Related]
8. Combination of UV and MS/MS detection for the LC analysis of cannabidiol-rich products.
Nemeškalová A; Hájková K; Mikulů L; Sýkora D; Kuchař M
Talanta; 2020 Nov; 219():121250. PubMed ID: 32887141
[TBL] [Abstract][Full Text] [Related]
9. Validation of an UHPLC/DAD method for the determination of cannabinoids in seized materials: Analysis of 213 samples sold in Belgian CBD shops.
Deville M; Dubois N; Denooz R; Charlier C
Forensic Sci Int; 2020 May; 310():110234. PubMed ID: 32200307
[TBL] [Abstract][Full Text] [Related]
10. Analysis of illicit drugs in purchased and seized electronic cigarette liquids from the United Kingdom 2014-2021.
Frinculescu A; Coombes G; Shine T; Ramsey J; Johnston A; Couchman L
Drug Test Anal; 2023 Oct; 15(10):1058-1066. PubMed ID: 35466538
[TBL] [Abstract][Full Text] [Related]
11. Development of a validated method for rapid quantification of up to sixteen cannabinoids using ultra-high-performance liquid chromatography diode-array detector with optional electrospray ionization time-of-flight mass spectrometry detection.
Song L; Carlson S; Valenzuela G; Chao M; Pathipaka SB
J Chromatogr A; 2022 May; 1670():462953. PubMed ID: 35334372
[TBL] [Abstract][Full Text] [Related]
12. Discrepancies between validated GC-FID and UHPLC-DAD methods for the analysis of Δ-9-THC and CBD in dried hemp flowers.
Duchateau C; De Leersnijder C; Barhdadi S; Canfyn M; De Braekeleer K; Deconinck E
Drug Test Anal; 2022 Oct; 14(10):1732-1743. PubMed ID: 35945003
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoids Tetrahydrocannabinol, Cannabinol, Cannabidiol, Tetrahydrocannabivarin and 11-nor-9-carboxy-∆9-THC in Hair.
Hill VA; Schaffer MI; Paulsen RB; Stowe GN
J Anal Toxicol; 2022 May; 46(5):487-493. PubMed ID: 34153110
[TBL] [Abstract][Full Text] [Related]
14. LC-MS/MS Assay for the Measurement of Cannabidiol Profiling in CBD Oil from Japanese Market and Application for Convertible Tetrahydrocannabinol in Acetic Acid Condition.
Takashina S; Takahashi M; Morimoto K; Inoue K
Chem Pharm Bull (Tokyo); 2022; 70(2):169-174. PubMed ID: 35110438
[TBL] [Abstract][Full Text] [Related]
15. CBD, a precursor of THC in e-cigarettes.
Czégény Z; Nagy G; Babinszki B; Bajtel Á; Sebestyén Z; Kiss T; Csupor-Löffler B; Tóth B; Csupor D
Sci Rep; 2021 Apr; 11(1):8951. PubMed ID: 33903673
[TBL] [Abstract][Full Text] [Related]
16. Absence of Relevant Thermal Conversion of Cannabidiol to Tetrahydrocannabinol in E-Cigarette Vapor and Low-Tetrahydrocannabinol Cannabis Smoke.
Hindelang P; Scharinger A; Golombek P; Laible M; Tamosaite S; Walch SG; Lachenmeier DW
Cannabis Cannabinoid Res; 2022 Oct; 7(5):616-620. PubMed ID: 36169637
[No Abstract] [Full Text] [Related]
17. Cannabidiol (CBD) product contamination: Quantitative analysis of Δ
Johnson E; Kilgore M; Babalonis S
Drug Alcohol Depend; 2022 Aug; 237():109522. PubMed ID: 35690015
[TBL] [Abstract][Full Text] [Related]
18. Origin of Δ
Citti C; Russo F; Linciano P; Strallhofer SS; Tolomeo F; Forni F; Vandelli MA; Gigli G; Cannazza G
Cannabis Cannabinoid Res; 2021; 6(1):28-39. PubMed ID: 33614950
[No Abstract] [Full Text] [Related]
19. Hair analysis for delta(9)-THC, delta(9)-THC-COOH, CBN and CBD, by GC/MS-EI. Comparison with GC/MS-NCI for delta(9)-THC-COOH.
Baptista MJ; Monsanto PV; Pinho Marques EG; Bermejo A; Avila S; Castanheira AM; Margalho C; Barroso M; Vieira DN
Forensic Sci Int; 2002 Aug; 128(1-2):66-78. PubMed ID: 12208025
[TBL] [Abstract][Full Text] [Related]
20. Analysis of cannabidiol (CBD) and THC in nonprescription consumer products: Implications for patients and practitioners.
Miller OS; Elder EJ; Jones KJ; Gidal BE
Epilepsy Behav; 2022 Feb; 127():108514. PubMed ID: 34998268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
